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ANP           atrial natriuretic peptide 
BNP           brain natriuretic peptide 
BMI           body mass index 
BP              blood pressure 
C                total arterial compliance 
CI               cardiac index 
CO              cardiac output 
CVD           cardiovascular disease 
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Ea               arterial elastance 
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hes               LV average wall thickness 
LV              left ventricle 
LVEDV      left ventricular end-diastolic volume 
LVEF         left ventricular ejection fraction 
LVESV      left ventricular end-systolic volume 
LVET         left ventricular ejection time  
IVSd           intra ventricular septum in diastole
NP              normal pregnancy 
Pb               pressure wave reflections backward
PE               preeclampsia/preeclamptic 
Pes              end-systolic pressure 
Pf                pressure wave reflections forward
Pp               postpartum 
PPEP          previous preeclamptic patients 
R                 peripheral arterial resistance 
RR              cardiac cycle length 
SBP            systolic blood pressure 
SV              stroke volume 
SVI             stroke volume index  
Z0                characteristic impedance 
VAC           ventriculo-arterial coupling  
Vcfc            velocity of circumferential fiber shortening 
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Introduction  
During pregnancy, the growing fetoplacental unit induces distinct changes in maternal 
physiology. The maternal cardiovascular adaptation to pregnancy normally involves changes 
in circulating blood volume (1), cardiac output (2) and peripheral vascular resistance (3). 
Healthy pregnancy is often referred to as a state of high cardiac output and low peripheral 
resistance. This hemodynamic state involves extensive alterations in all aspects of maternal 
cardiovascular function such as myocardial function and contractility, heart rate, and vascular 
properties. Myocardial function during pregnancy has discrepantly been described as being 
either normal, depressed, or enhanced (4, 5). Healthy women adapt well to these 
cardiovascular changes which are induced by the hormonal influence of the growing 
fetoplacental unit, and thereby secure adequate delivery of oxygenated blood to peripheral 
tissues and the fetus. Adverse cardiovascular events are rare during healthy pregnancy. 
However, women with pre-existing cardiovascular disease may not be able to fully 
accommodate to pregnancy. Furthermore, undiagnosed heart disease may be disclosed during 
pregnancy due to the increased cardiac demands induced during pregnancy.  
   Worldwide, hypertensive disorders of pregnancy represent an important clinical problem 
with a significant maternal and perinatal morbidity and mortality (6). Hypertensive disorders 
of pregnancy are classified into two categories, pre-existing or gestational, and further 
complicated with preeclampsia. Preeclampsia is defined as pregnancy-induced hypertension 
with proteinuria occurring after 20 weeks of gestation. Preeclampsia occurs in 3-10% of all 
pregnancies (6). In western countries, the prevalence has been reported to increase over the 
last 30 years (7). Accordingly, an increase in prevalence from 3.3 to 4.5% has been reported 
in Norway from 1968 to 2002 (8). The mechanism and pathogenesis of this entity are still not 
well understood. This is partly due to the fact that preeclampsia refers to a set of symptoms, 
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and is a heterogeneous condition. Over the last decades it has become apparent that 
preeclampsia is not a homogenous condition with a single cause. Preeclampsia is the final 
response to an interaction between maternal (pregnancy-independent) and trophoblast 
(placenta-dependent) factors. In each individual woman the placental and maternal factors act 
in concert, and contribute to various degrees of cardiovascular, uteroplacental, metabolic, 
immunological, and neuro-endocrine changes that occur in preeclampsia. The cardiovascular 
system, however, will always become affected in preeclampsia as reflected by the 
hypertension and capillary leakage with proteinuria and edemas associated with this 
condition. Endothelial dysfunction seems to play a key role in the pathogenesis of 
preeclampsia (Figure 1).  
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Figure 1. How the preeclamptic maternal response to the trophoblast affects the maternal systemic 
circulation (T. Henriksen). 
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As outlined above, healthy pregnancy is characterized by high cardiac output and low 
peripheral vascular resistance. In preeclampsia, the situation is often reversed with a 
hemodynamic profile more comparable to the non-pregnant state with high vascular resistance 
(9, 10). Other aspects of vascular properties, such as total arterial compliance and proximal 
aortic stiffness, have to some extent been studied in the preeclamptic population. Noninvasive 
investigations using pressure and flow estimates indicate that total arterial compliance is 
reduced, and proximal stiffness increased in preeclampsia (11, 12). Furthermore, there are 
some data indicating that increased sympathetic activity in these patients (13) may contribute 
to the typical hemodynamic state. There is extensive evidence that endothelial dysfunction 
plays a central role in the pathogenesis of preeclampsia that readily explains many of the 
cardiovascular, inflammatory, hematological, and clinical characteristics of the preeclamptic 
patient (14).    
   Currently, research in the area of hemodynamics and arterial properties in normal pregnancy 
and preeclampsia has several aspects. First, there is a need for detailed insight into the natural 
course of physiological changes during healthy pregnancy in order to define the normal 
ranges of hemodynamic parameters. Such knowledge is relevant for health professionals 
handling women in childbearing age as a theoretical background when facing pathological 
pregnancies or women with pre-existing medical conditions that may become influenced by 
pregnancy. Second, it is becoming increasingly evident that the different subgroups of 
preeclampsia are pathogenetically at least partly diverse (14) and need further description. 
Third, the significant increase in risk of cardiovascular disease later in life in previous 
preeclamptic women warrants data that provide pathophysiological insight that can improve 
health advice to women at risk (15). Given that the cardiovascular system is affected in 
normal pregnancy, becomes deranged in preeclampsia, and that preeclampsia is an indicator 
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of future cardiovascular risk, investigations of the cardiovascular system in pregnant women 
should be an important element in studies of women’s health.   
   Studies of cardiovascular adaptations in the pregnant population are particularly challenging 
since these must be carried out without any fetomaternal risk or discomfort. Ideally, the 
investigations should be brief, harmless and without need for sedatives in order to avoid 
fetomaternal risk and alterations of normal maternal cardiovascular physiological state.  
   Noninvasive methods have been developed that enable a detailed assessment of systemic 
arterial properties and left ventricular (LV) function. By use of simultaneous 
echocardiography and recording of external arterial pressure waveforms, systemic vascular 
properties, i.e. peripheral resistance, total arterial compliance and characteristic impedance, 
can be estimated (16-18). Understanding of LV performance requires not only examining the 
properties of the LV itself, but also investigating the effects of the arterial system on the left 
ventricular performance. The interaction between the LV and the arterial system, i.e. the 
ventriculo-arterial coupling (Ea/ELV), is an important determinant of cardiovascular 
performance and cardiac energetics, and has hitherto not been described in detail in neither 
normal nor pathological pregnancy.  
   The results of the present studies are all obtained by a comprehensive analysis of 
longitudinal cardiovascular data recorded by entirely non-invasive techniques and 
demonstrate important cardiovascular adaptations during healthy and pathological 
pregnancies. 
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Aims of thesis 
The aims of the present work were: 
Specific 
1. To perform a clinical longitudinal study with comprehensive assessment of left ventricular 
function by echocardiographic measurements in normal pregnancy and postpartum (Paper 1). 
2. To perform a longitudinal study with comprehensive assessment of systemic arterial 
properties and ventriculo-arterial coupling during normal pregnancy and postpartum (Paper 
2). 
3. To evaluate and compare changes in brachial arterial blood pressures during healthy 
pregnancy measured by two different non-invasive measurement devices (Paper 3). 
4. To assess and compare systemic arterial properties and ventriculo-arterial coupling in 
normal pregnancy, acute preeclamptic pregnancy, and previous preeclamptic pregnancy 
(Paper 4). 
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Subjects  
Three different groups of women were studied; group 1 comprised women with normal 
pregnancies (NP), group 2 women with acute preeclamptic pregnancies (PE), and group 3 
women with previous preeclamptic pregnancies (PPEP). Written informed consent was 
obtained from all participants. The study was approved by the Regional Committee for Ethics 
in Medicine. All women received conventional medical treatment at the discretion of the 
responsible physician.  
Group 1 Normal pregnancy (NP) 
Group 1 comprised healthy women with defined normal singleton pregnancy in the first 
trimester. 70 women referred to the STORK project at the Obstetric Department at 
Rikshospitalet in the period of January 2008 to June 2008, were invited to participate in the 
follow up study. They were investigated at weeks 14-16 (65) (there were 5 drop-outs), weeks 
22-24 (63), week 36 (61) and 6 months postpartum (63). Two women dropped out of the 
study because of spontaneous abortion after the first investigation, and two were lost for the 
36 weeks control because of pre-term birth. Serial foetal ultrasound examinations were 
performed by a gynecologist confirming normal foetal anatomy and growth in all study 
subjects. 
Group 2 Preeclamptic pregnancy (PEP) 
Group 2 comprised 40 women diagnosed with preeclampsia as defined by hypertension 
(blood pressure > 140/90 mmHg) and proteinuria (i.e. urine protein to creatinine ratio above 
30 mg/mmole creatinine or at least +1 proteinuria on urine stix on two occasions at least 24 
hours apart) before delivery at any time point in pregnancy. The participants were recruited 
from the patients referred to the Department of Obstetrics at Rikshospitalet for evaluation and 
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treatment of preeclampsia in the period January 2008 to January 2009. Six months 
postpartum, 35 of the 40 women (i.e. 5 drop-outs) underwent a second investigation. 
Group 3 Previous preeclamptic pregnancy (PPEP) 
Group 3 comprised non-pregnant women who had been diagnosed with preeclampsia in 
previous pregnancies (delivered with preeclampsia at Rikshospitalet in the period July 2003 to 
June 2008). All patients referred for evaluation and treatment of preeclampsia at the 
Department of Obstetrics at Rikshospitalet in that period constitute a database of 
approximately 500 patients.  From this database, we randomly selected 50 patients who were 
invited to participate in the study, of which 40 women agreed to participation.  
I. Baseline and follow up investigations for women with normal pregnancy (NP) 
Investigation:         w 14-16          w 22-24            w 36                    6 mo pp   
Clinical status  x  x  x   x   
BP, ECG              x  x  x   x   
Echocardiography x  x  x   x 
Tonometry  x  x  x              x  
Blood sample  x  x  x   x 
II. Baseline and follow up investigations for women with preeclamptic pregnancy (PE) 
Investigation:        at term       6 mo pp   
Clinical status  x  x    
BP, ECG  x  x      
Echocardiography x  x   
Tonometry  x  x    
Blood sample  x  x      
20
III. Investigations of women with previous preeclamptic pregnancy (PPEP) 
Clinical status             x 
BP, ECG                     x      
Echocardiography      x    
Tonometry             x     
Blood sample             x  
In group 3 (PPEP), body mass index (BMI) and blood pressure (BP) in 1.st trimester, 
gestational age at diagnosis of preeclampsia, gestational age at delivery and birth weight were 
recorded during index pregnancy. Furthermore, peak urine protein/creatinine ratio, peak 
systolic and diastolic BP and antihypertensive medication at delivery were registered. Level 
of physical activity and family history of cardiovascular disease (CVD) were reported.    
     
Exclusion criteria 
Group 1 
Hypertension (i.e. BP > 140/90 mmHg). Proteinuria (as above). 
Group 1, 2 and 3  
Previous myocardial infarction documented by ECG, history and/or typical cardiac enzyme 
pattern. Previous stroke with sequelae. Any condition which interferes with patient’s 
possibility to comply with protocol. Significant mental disorder. Uncontrolled 
endocrinological and reumathological disturbances, and kidney disease. 
21
Methods 
Echocardiography  
Echocardiography was performed with the subjects in a left decubitus posisition. Subjects 
were scanned from the parasternal and apical windows (19) by use of a digital ultrasound 
scanner (Vivid 7, GE Vingmed, Horten, Norway). We recorded conventional grey scale 
cineloops, pulsed and continuous wave Doppler recordings of blood flow velocities, and 
tissue-Doppler cineloops of LV. Frame rate during tissue-Doppler recordings was >100 
frames per second (FPS) and during 2D-imaging >40 FPS. We used at least 3 consecutive 
cineloops which were obtained and stored on server for off-line analysis using dedicated 
software (Echopac version 7.0; GE).  
   The parameters left ventricular end-diastolic volume (LVEDV), end-systolic volume 
(LVESV), and ejection fraction (LVEF) were calculated by use of the Simpson’s modified 
biplane method utilizing endocardial contours in the apical 4 and 2 chamber view (20). LV 
mass was calculated from parasternal M-mode registrations according to the Devereux 
formula, obtained by 2D of LV dimensions (average of short and long axis recording) (21).   
   Pulsed Doppler blood flow velocities were recorded at the mitral valve ring and tip, and in 
the LV outflow tract. Cardiac output (CO) was calculated from stroke volume (SV) 
(determined by pulse wave Doppler recordings) multiplied by heart rate (HR). The mitral 
peak early (E) and late (A) diastolic flow velocities were measured, and the E to A ratio and E 
deceleration time were calculated (22).  
   Pulsed Tissue Doppler recordings were obtained using a predefined 9 mm sample volume 
positioned at the septal and the lateral aspects of basal LV at the junction with the mitral 
annulus in the apical 4-chamber view (Figure 2) (23). Diastolic peak early (e’) and late (a’) 
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mitral annular tissue velocities as well as peak systolic velocity (s’) are reported as the 
average of the septal and lateral annular values. The E/e’ ratio was calculated (22). The 
parameters derived from Doppler and tissue-Doppler recordings were measured after 5 min 
rest with the woman in a left ducubitus posisition on at least 3 consecutive heart cycles and 
averaged.  
Figure 2. Pulsed Tissue Doppler recordings were obtained using a predefined 9 mm sample volume 
positioned at the septal and the lateral aspects of basal LV at the junction with the mitral annulus in 
the apical 4-chamber view. 
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Strain is defined as fractional change of tissue length and is expressed in a dimensionless unit 
conventionally as percent shortening (negative values). Strain values can be derived from 
tissue Doppler recordings, as well as from tracking of ultrasound speckle patterns. In this 
work, we used the latter approach. Briefly, speckles represent consistent ultrasound reflection 
patterns from tissue. Speckle presence is due to interference effects between overlapping 
echoes, and its occurrence is related to randomly distributed structure scatterers within a 
resolution cell. The software algorithm tracks the speckles from frame to frame and calculates 
the distance between the speckles during the heart cycle. These distance measurements 
provide accurate tracking of the myocardial contraction and relaxation patterns during cardiac 
cycle. Two-dimensional speckle tracking (2D-STE) grayscale images were acquired in apical 
4 chamber, 2 chamber and long axis views. Figure 3 displays strain curves from a healthy 
individual. The predominant fiber orientation is longitudinal in the subendocardium and 
circumferential in the mid-myocardium. Longitudinal strain predominantly reflects 
subendocardial myofiber contraction while contraction durations by circumferential strain 
measure mid-myocardial contraction. We assessed peak longitudinal systolic strain in all 16 
segments of the LV. Peak systolic global strain (GS) was assessed as the average of segmental 
strains, and used to assess global LV myocardial function (24). 
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Figure 3. Speckle tracking longitudinal strain curves from 6 segments in apical 2 
chamber view from a healthy pregnant individual. 
   All echocardiographic recordings were performed and analysed by one investigator (MEE). 
All echocardiographic analyses were performed offline with the observer blinded for time 
point. 
LV contractility 
In general, cardiac imaging techniques, as echocardiography, provide access to LV 
contractions which depend on the myocardial contractility, but is not equivalent. LV 
contractility is the result of the intrinsic contractile properties of the myocytes, but is also 
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influenced by the ventricle’s loading condition and heart rate. LV contractility cannot be 
measured by presently available imaging techniques, but can be approached and analysed in a 
framework where LV contractions and afterload are incorporated (25). We used the 
noninvasively obtainable and preload-insensitive measure of contraction, mean velocity of LV 
circumferential fiber shortening normalized for heart rate (Vcfc) plotted against LV afterload 
measured as LV end-systolic wall stress (25) (Figure 4). Vcfc was obtained as LV fractional 
shortening (FS, i.e. end-diastolic minus end-systolic diameter over end-diastolic diameter) 
over ejection time (LVET, determined from echocardiographic registrations), and normalized 
for heart rate (HR) by dividing with the square root of cardiac cycle length (RR);  
Vcfc = FS%/LVET/RR1/2. 
LV meridional end systolic wall stress (ESWS or ıes) (dyn), a measure of LV afterload was 
calculated in end-systole as  
                                  ıes = Pes x Des/(4hes [1+hes/Des]) 
where Pes (mmHg) is end-systolic aortic root pressure (determined from tonometric pressure 
estimate), Des (cm) is LV mean inner diameter at end-systole, and hes (cm) is LV average wall 
thickness (septum and posterior wall obtained from parasternal midventricular  LV guided by 
2D echo (average of short and long axis recordings) obtained from leading edge to leading 
edge at end-systole (26).  
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Figure 4. (25) 
   We used the mean velocity of LV circumferential fiber shortening normalized for heart rate 
(Vcfc), global strain (GS) and ejection fraction (EF) plotted against LV afterload measured as 
LV end-systolic wall stress (ESWS), to analyse the change in contractility during normal 
pregnancy.  
Tonometry, external pulse trace 
The right subclavian artery pulse waveform was obtained by high-fidelity external 
applanation tonometric device (Millar SPT-301, Millar Instruments Inc., Houston, Tx, USA) 
and represents the aortic root pressure waveform well (27). 
   The pulse transducer was manually positioned over the right subclavian artery in the medial 
supraclavicular region, and the pulse was traced if possible during a brief period of apnea 
close to end of expiration in order to reduce baseline drift during respiration. The pulse 
transducer was lightly positioned over the right subclavian artery with the women in the left 
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lateral position (Figure 5). Recordings were performed semi-simultaneously (i.e. < 5 min) 
with Doppler blood flow recordings with maintained subject position. 
  
                        
Figure 5. Technique for recording of subclavian artery pulse trace is shown in the left upper panel. 
The raw data recordings are shown in the right top panel. Selected cycles that are used to calculated 
the average pressure waveform is emphasized with thicker lines on the right top panel. The average 
waveform is shown in the bottom panel, calibrated by averaged systolic and diastolic blood pressure.
Osc DBP
Osc SBP
Pes
Averaged SPT
Tonometer, Millar SPT 203
Osc. BA BP
Best sequence of pulse traces 
st sequence of pulse traces
calibrated by osc. BP
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Figure 6. From the Matlab program, Doppler recordings. The raw data recordings are shown in the 
left panel. The operator draws points on the flow image to derive the aortic flow over three cycles. 
Selected cycles from Doppler registrations in LVOT that is used to calculate the average waveform is 
shown in the upper right panel. The average flow signal from 3 selected waveforms is shown in the 
lover right panel.  
The tonometric recordings were performed at the end of the echocardiographic examination 
briefly after the Doppler recordings (i.e. < 5 min) with unchanged study subject state and 
position. Time consumption for tonometry was approximately 5 min. The dedicated software 
which we used (28) (customised in MatLab 7, MathWorks ™ Inc, Natick, Massachusetts, 
USA) (Figure 5, 6) enables immediate analysis of data. The tonometric signal was 
automatically and simultaneously transferred to a personal computer for amplification and 
processing (28). In order to perform analyses, at least 3 cardiac cycles with adequate 
tonometric pulse tracing and LVOT Doppler blood flow signals were selected (Figure 7). 
Feasibility for the subclavian arterial pulse trace recordings was 95%, with 5% exclusions 
because of suboptimal waveform quality. The subclavian arterial waveform was calibrated to 
its peak and nadir by brachial arterial systolic and diastolic blood pressure measurements, 
(taken after 10 min rest) which was obtained by automatic oscillometric technique (Dinamap 
ProCare 300-Monitor, Criticon, GE medical systems, USA) using a pneumatic cuff on the 
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right upper arm. Triple recordings were obtained, and the mean systolic and diastolic 
pressures were assessed as the mean of the 3 recordings.  
Figure 7. Illustration of the procedure to extract the average pressure and flow waveforms over one 
cardiac cycle. The raw data recordings are shown in the top panel. Selected cycles that are used to 
calculated the average pressure waveform is emphasized with thicker lines on the left. The operator 
draws points on the Doppler flow image to derive the aortic flow over 3 cycles as shown on the right. 
The average waveforms are shown in the middle panel and the bottom panel shows alignment of 
pressure and flow (paper IV). 
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Systemic arterial properties  
The dedicated software we used (28) (customised in MatLab 7, MathWorks ™ Inc, Natick, 
Massachusetts, USA) enables immediate analyses of data on the various aspects of systemic 
arterial properties. The software calculated systemic arterial properties which were estimated 
from aortic root blood flow and pressure estimates by use of both a Fourier analysis and an 
estimation of  parameters of a 3-element windkessel model of the systemic circulation (28, 
29) (Figure 8). In this model it is assumed that peripheral vascular resistance is constant, flow 
out of the systemic arteries is proportional to the pressure drop, venous pressure is negligible, 
the pressure is equal in the entire systemic arterial tree, and arterial compliance is constant 
during the cardiac cycle (29). 
Z0
RCP(t)
Q(t)
Systemic arterial properties were characterized and described by peripheral arterial resistance 
(R), characteristic impedance (Z0), total arterial compliance (C) and effective arterial elastance 
(Ea). Total peripheral vascular resistance, R was estimated as the ratio of mean arterial 
Figure 8. Diagram of the lumped parametre 3-element Windkessel model used to estimate 
systemic arterial properties. Measured blood flow as a function of time [Q(t)] and arterial 
pressure wave form as a function of time [P(t)] were inputs to the model. Z0, characteristic 
impedance of the proximal aorta; C, total arterial compliance; R, total peripheral resistance. 
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pressure to cardiac output. Characteristic impedance, Z0 reflects proximal aortic stiffness or 
resistance. This parameter was calculated both by Fourier analyses of the flow and pressure 
curves, as the average of amplitudes at high-frequency harmonics (3 – 10 Hz) and also as a 
parameter of the 3 element analogue lumped windkessel model (Figure 8). Total arterial 
compliance, C reflects the volume compliance of the entire systemic arterial tree, and was 
calculated using the pulse pressure method (PPM) and was also available as a parameter from 
the 3- element windkessel model (30). Ea was calculated by the ratio of ventricular end-
systolic pressure (Pes) to stroke volume (SV) (determined by pulse wave Doppler recordings). 
In Paper 2 we also used the frequency-domain estimate of Z0 for the wave separation analysis, 
and pressure wave reflections in the aorta were analyzed. The pressure wave can be separated 
into its forward (Pf) and backward (Pb) traveling component (i.e., the reflected wave) by use 
of pressure, flow and characteristic impedance data as follows: Pf = (P+Z0Q)/2 and  
Pb = (P-Z0Q)/2 (31). The reflection magnitude is given as the ratio of the amplitudes of Pb 
and Pf (Pb/Pf) (31). 
Ventriculo-arterial coupling  
In this section a method is presented to assess whether the heart operates on optimum power 
or efficiency, using hemodynamic principles. ELVI represents the left ventricular systolic 
elastance index and is calculated as Pes/ESVI (thus neglecting the volume intercept of the 
end-systolic pressure volume relationship, V0). Optimum power or efficiency, is assumed 
measures of ventriculo-arterial coupling (Ea/ELV) which is the interaction of the LV with the 
arterial system. Ea/ELV is a central determinant of cardiovascular performance and cardiac 
energetics. Ea/ELV can be indexed by the ratio of effective arterial elastance (Ea; a measure of 
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the net arterial load exerted on the left ventricle) to LV end-systolic elastance (ELV; a load-
independent measure of left ventricular chamber performance). Effective arterial elastance, 
Ea, was calculated as end systolic pressure (Pes) divided by stroke volume (SV), and then 
indexed by body surface area, to yield EaI (32).  Effective arterial elastance shares common 
units with elastance measures of left ventricular function ELV, which also was indexed for 
body surface area (BSA) (ELVI). Indexation of parameters measured during pregnancy is 
debated because of weight gain in pregnancy; in the fraction EaI/ELVI, however, the 
indexation parameter m2 will be eliminated.  
   The ratio between arterial and LV elastance (EaI/ELVI) is regarded to be an index of 
ventriculo-arterial coupling. From the definitions of EaI and ELVI and the approximation that 
V0 § 0, it follows that EaI/ELVI = ESVI/SVI (33) (Figure 9). 
   At rest, in healthy individuals, Ea/ELV is maintained within a narrow range, which allows 
the cardiovascular system to optimize energetic efficiency at the expense of mechanical 
efficacy. 
   In the normal physiological resting state, EaI/ELVI varies between 0.5 and 1.0, where values 
close to 0.5 indicate a maximal cardiac efficiency whereas values approaching 1.0 indicate 
maximal external cardiac work (34) thus providing a framework for analysis of cardiac 
performance and efficiency (30, 35). 
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Figure 9. Schematic representation of the left ventricle pressure-volume diagram and the method used 
to determine the parameters of ventriculo-arterial coupling. Ea, Effective arterial elastance; EDV, 
end-diastolic volume; ELV, left ventricular elastance; ESV, end-systolic volume; Pes, left ventricular 
end-systolic pressure; SV, left ventricular stroke volume; V0, volume axis intercept of the end-systolic 
pressure-volume relationship. From the approximation V0 ≅ 0, it follows that ELV ≅ Pes/ESV (33).  
Brachial arterial blood pressure 
The blood pressure was taken at every control and after 5 minutes of rest with the women in 
the left lateral ducubitus position. We used a pneumatic cuff on the right upper arm, and 
brachial arterial systolic and diastolic blood pressures were obtained in triplicate. The blood 
pressure was measured by oscillometric technique with Dinamap ProCare 300-Monitor 
(Criticon, GE medical systems, USA). Blood pressure measurements during pregnancy is 
debated, however the Dinamap ProCare 300 uses the same algorithm modelled on a mercury 
sphygmomanometry reference standard as the Dinamap® ProCare 400 which has been 
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validated in pregnancy and achieved the accuracy grade (A/A) according to the BHS protocol 
and AAMI recommendations (36).
Finometer 
Finometer PRO is a noninvasive measurement device with a continuous registration of finger 
arterial pressure waveform. The device measures finger arterial pressure, based on the volume 
clamp method by Penaz co-workers (37, 38) and the physical criteria of Wesseling et al. (39). 
Individual level correction for systolic blood pressure was made through the return-to-flow 
(RTF) calibration. By application of an appropriate waveform filter that corrects the pulse 
wave distortion in addition to RTF calibration, the method meets the Association for the 
Advancement of Medical Instrumentation (AAMI) recommendations in pregnant participants 
(40). The recording started with the women in a sitting position on a comfortable bed. 
Recordings were performed with an appropriately sized finger cuff applied to the middle 
finger on the women’s right hand and an upper arm cuff on the right arm. The height 
correction device was kept at heart level in order to avoid the effect of hydrostatic pressure 
(41). After obtaining a stable signal, the finger pressure recording was corrected against the 
brachial arm cuff pressure by the RTF method (42, 24). The women then lay down in a 30-
degree left lateral tilt position to avoid aortic-caval compression. After falling to rest, a 120 
second period of continuous blood pressure recording was obtained. 
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Reproducibility  
Recordings from 25 randomly selected study subjects, both echocardiographic recordings and 
tonometric recordings were re-analyzed by an independent and echocardiographically 
experienced investigator (JOB), and by an independent and tonometrically experienced 
investigator (LAR). Intraobserver repeatability was obtained from the two measures of 
observer A (ME), as the mean difference with standard deviation and the intra-class 
correlation coefficients (ICC). Inter-observer repeatability was obtained using the same 
parameters from the measurements of observer A and B (JOB/LAR), respectively. For 
LVEDV intra- and interobserver repeatability were (mean ± SD) 1 ± 12 mL (ICC 0.81) and 1 
± 2 mL (ICC 0.89). For EF intra- and interobserver repeatability were 1.0 ± 3.0% (ICC 0.87) 
and 1.0 ± 3.0% (ICC 0.90). For GS intra- and interobserver repeatability were 1.3 ± 1.6% 
(ICC 0.81) and 0.3 ± 1.0% (ICC 0.83). For MAP intra- and interobserver repeatability were 
1.0 ± 3.4 (ICC 0.97) and 1.1 ± 6.8 mmHg (ICC 0.92). For Pes, intra- and interobserver 
repeatability were 1.2 ± 3.9 (ICC 0.97) and 1.8 ± 7.3 (ICC 0.91).  
Statistical analyses 
Since we had no pregestational data, we defined the recordings at 6 months post partum as 
reference point, assuming that hemodynamic and vascular properties then had returned to 
normal (2). Continuous data are presented as mean ± standard deviation (SD). The changes in 
hemodynamic data during the 3 subsequent follow-up time-points during normal pregnancy 
and 6 months follow-up were analyzed by mixed model analysis that accounts for the positive 
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correlations between repeated measurements. Bonferroni post-hoc tests were applied. 
Correlations between variables were obtained by Pearson correlation coefficients. Unpaired t-
test was used to compare wall thickness between nullipara and multipara women. Paired t-test 
was used to compare data between normal pregnancy at term and postpartum and one way 
ANOVA with appropriate post-hoc testing for multiple comparison was used to compare 
postpartum data between normal, preeclampsia, and previously preeclamptic pregnancy 
(Paper 4). All statistical analyses were performed with SPSS statistical software (SPSS 16.0 
Inc. Chicago). We considered p < 0.05 as statistically significant.
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Summary of results 
Paper 1 
In this study, by use of echocardiography and calibrated subclavian artery pulse trace, we 
found altered LV function during normal pregnancy when compared to 6 months postpartum 
control. The altered LV function during pregnancy (Table 1) was characterized by impaired 
LV EF, GS and Vcfc, i.e. LVEF decreased by 11%, GS was slightly (6%) reduced at week 36 
as compared to weeks 22-24, and Vcfc was reduced by 6%. Furthermore, Vcfc was 
significantly decreased from 14-16 weeks to 22-24 weeks while afterload was essentially 
unchanged. Basal myocardial peak systolic longitudinal velocity, s’, remained unchanged. LV 
end-systolic wall stress was reduced by 12% at 22-24 weeks as compared to 36 weeks and 6 
months postpartum. Cardiac output and cardiac index (CI) increased significantly by 20% and 
15% respectively, throughout pregnancy as compared to the control 6 months postpartum. 
Furthermore, systolic and diastolic blood pressures were reduced during pregnancy, and 
returned to normal values 6 months postpartum. During pregnancy, LVEDV increased by 
23% returning to normal values 6 months postpartum.   
   There were only minor varieties in diastolic function and filling pressures during pregnancy. 
LV filling pressure was characterized by essentially unaltered E/e, transmitral E wave velocity 
decreased by 12.5% from weeks 12-14 to week 36, and was thereafter maintained reduced at 
6 months postpartum. E/A ratio decreased by 17.6% from weeks 14-16 to week 36. Mitral E 
wave deceleration time was unchanged. e’, a marker of diastolic function, was significantly 
reduced at 36 weeks compared to 14-16 weeks, and maintained reduced at 6 months 
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postpartum. Left atrial area increased by 17% during pregnancy, returning to normal values 6 
months postpartum. 
   These findings suggest that pregnancy represents a larger load on the cardiovascular system 
than previously assumed.  
  
14-16 w 22-24 w 36 w 6 mo pp P
EF % 61 ± 6 59 ± 9 54 ± 8*# ¤ 60 ± 8 <0.01
GS % -19.0 ± 3.2 -19.6 ± 2.2 -18.1 ± 2.4¤ -19.2 ± 2.7   0.02 
Vcfc (circ/s) 1.23 ± 0.16 1.14 ± 0.20* 1.18 ± 0.21 1.24 ± 0.14 <0.01
ıes (dyn s cm-5) 90.2 ± 22.6 87.3 ± 26.8* 99.5 ± 23.3¤ 99.1 ± 19.9 <0.01
Table 1. LV shortening and ES wall stress. Mean ± SD.  p < 0.05 vs *6 mo postpartum, #14-16 w,  
¤22-24 w, §36 w. 
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Paper 2 
In this study we assessed systemic arterial properties and interaction between the left ventricle 
(LV) and systemic arteries during NP by echocardiography and tonometry.  
   The study subjects were the same population as in Paper 1. Cardiac output increased by 
20% and blood pressure decreased by 10% as compared to 6 months postpartum control. 
Systemic arterial properties during pregnancy showed reduced peripheral vascular resistance 
with a nadir at 22-24 weeks whereas proximal aortic stiffness (Z0) and total arterial 
compliance (C) were not significantly changed (both were measured by windkessel model and 
the pulse pressure method) The arterial elastance index, EaI decreased significantly at weeks 
14-16 and 22-24 as compared to 6 months postpartum by a magnitude of 21%. The LV 
elastance index, ELVI, was significantly decreased at weeks 22-24 and at 36 weeks. The 
magnitude of decrease in ELVI was 29%. Early in pregnancy and postpartum, the ventriculo-
arterial coupling index EaI /ELVI, averaged 0.45 ± 0.14. In third trimester, when comparing to 
6 months postpartum the index had increased significantly to 0.64 ± 0.23.  
   Thus, during NP there is an increase in cardiac output, and decrease in blood pressure and 
peripheral arterial resistance whereas central aortic properties are less altered. The increased 
ventriculoarterial coupling index (EaI /ELVI) during NP indicates a decrease in LV function 
not fully compensated for by vascular adaptation. 
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Paper 3 
In Paper 3 systolic blood pressure (SBP), diastolic blood pressure (DBP), and mean arterial 
pressure (MAP) were measured during pregnancy by two different measurement devices, 
Finometer and Dinamap, and compared. We found that SBP, DBP, and MAP reached a 
statistically significant trough at gestational age 22–24 weeks when using both measurement 
devices. When compared with the nonpregnant measurement, SBP at gestational age 22–24 
weeks was 6.2 mmHg lower measured by Finometer and 7.2 mmHg lower measured by 
Dinamap. Furthermore DBP and MAP were 8.9 mmHg and 9.8 mmHg lower measured by 
Finometer. Measured by Dinamap, DBP and MAP were 4.5 mmHg and 5.4 mmHg lower at 
gestational age 22–24 weeks when compared with the nonpregnant state. We found that 
pregestational body mass index (BMI) had influence on SBP; SBP being significantly higher 
in women with pregestational BMI at least 25 kg/m2 with both measurement devices. 
However there were no differences in SBP, DBP, or MAP depending on parity or excessive 
weight gain. 
   Thus, BP measured repeatedly by two different noninvasive devices during pregnancy and 
postpartum showed a statistically significant drop in mid-pregnancy, followed by a 
progressive increase until term. 
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Paper 4  
In paper 4 we combined the methods from paper 1 and 2, and compared normal pregnancy 
(NP) with acute preeclamptic pregnancy (PE), and previously preeclamptic pregnancy 
(PPEP).  The hemodynamics and systemic arterial properties were characterized as follows:  
MAP was 17% higher at term in the PE group compared with postpartum. MAP was 35% 
higher at term and 14% higher postpartum in PE when compared with the corresponding 
values in NP and 17% higher in PPEP. In the PE group, total peripheral resistance (R) was 
maintained unchanged from term to postpartum. In NP, R was 16% lower at term than 
postpartum. R was 23% higher at term and 3% higher postpartum in the PE group compared 
with NP.  
   At both term and 6 months postpartum the systemic arteries were stiffer in the PE group 
compared to NP. This was as reflected by elevated Z0 (37% higher, mean of the 3-element 
windkessel model and the frequency domain analysis), and reduced C (12% lower, mean of 
the 3-element windkessel model and the pulse pressure method) and Ea (25% higher) at term. 
Furthermore Z0 was 18% higher, C was 7% lower, and Ea 11% higher in PE than in NP 
postpartum.  
   Women with PPEP had higher blood pressure than NP (17%). R was not different between 
the groups, however were both Z0 (39%) and Ea (14%) higher. EaI was higher in PE patients 
at both term and postpartum and in PPEP as compared to NP patients. Whereas ELVI was 
lower at term in NP compared to 6 months postpartum no such difference was observed in the 
PE group. However the ELVI was almost twice as high at term in PE patients as compared to 
at term levels in the NP group. This leads to a higher coupling index value, EaI/ELVI, in NP at 
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term as compared to both PE patients at term and to NP postpartum. In PPEP, EaI/ELVI was 
higher than NP at 6 months postpartum.  
   Thus, the altered arterial properties persisted after six months and were elevated three years 
postpartum in PPEP indicating that preeclampsia is associated with persistent cardiovascular 
disturbances.
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Discussion 
Pregnancy represents a unique model of morphological, hemodynamic, and functional 
adaptation of the heart in a physiological situation with significant transient changes in 
cardiac loading conditions and work requirements. A well defined characterization of 
maternal cardiac function during normal pregnancy is a prerequisite for identification of 
cardiac pathology. This is clinically highly relevant since heart disease is the leading cause of 
non-obstetric mortality during pregnancy. In parts of this thesis we assessed the effects of 
hemodynamic changes during normal pregnancy on LV function by use of echocardiography 
and tonometry. Moreover, it has been shown that a cardiovascular maldaptation to pregnancy 
impairs maternal cardiovascular health later in life. Thus pregnancy is now considered a stress 
test to the maternal cardiovascular system. This indicates that women planning to become 
pregnant should be screened for clinical and biochemical cardiovascular risk, and importantly, 
women presenting hypertension in pregnancy should be thoroughly investigated, treated and 
followed according to recommendations.  
Left ventricular function during normal pregnancy 
In paper 1 we found a significant increase in cardiac output, cardiac index and heart rate 
during normal pregnancy, which is expected and concordant with previous smaller studies 
(43, 44). Furthermore our data indicate that LV contraction and contractility is reduced during 
pregnancy. We found that LV ejection fraction was significantly reduced during pregnancy, 
and simultaneously we found a slight, but significant reduction in global strain in the last 
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trimester, compared to the measurement at gestational weeks 22-24. These findings together 
suggest that LV function is reduced during pregnancy. A more comprehensive analysis of 
contraction and contractility was obtained by incorporating LV loading conditions in the 
analysis. There are only a few studies on LV function which take into account the effects of 
loading conditions (45-49). We plotted the preload-insensitive parameter of LV contractility, 
Vcfc, against LV afterload measured by LV end-systolic wall stress (50), and observed that 
Vcfc was significantly reduced at 22-24 weeks compared to the reference measurement 6 
month post partum (Figure 10). This finding suggests that not only LV contractions but LV 
contractility is transiently reduced during pregnancy. When plotting EF and global strain 
against LV afterload (Figure 11, 12) much of the same pattern appears. 
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Figure 10 . LV EF % vs. ES wall stress. Mean ± SE.  p < 0.05 vs *6 mo post partum, †14-16 w,  ‡22-
24 w, §36 w. 
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The expected LV systolic response to reduced afterload, given unchanged contractility, is 
increased shortening. However we found reduced Vcfc and longitudinal global strain at time 
point 14-16 weeks and reduced Vcfc and EF at time point 22-24 weeks, as compared to the 6 
months postpartum reference. These findings suggesting that reduction in LV contractility 
begins in second trimester and is maintained to partum. Despite the fact that noninvasive 
measurements of contractility is debated, we think that the consistent leftward displacement of 
EF, GS and Vcfc during pregnancy (time-points 1, 2 and 3 in Figure 10-12) as compared to 6 
months postpartum (time-point 4 in Figure 10-12), substantiates that LV contractility is, albeit 
transiently, truly reduced during pregnancy. 
   The finding of increased septal and posterior wall thickness during pregnancy (Paper 1) has 
been reported in previous smaller studies (51-53). However, the sustained increase in wall 
thickness that we found at 6 months postpartum has not previously been observed. Pregnancy 
is regarded in the literature to promote a reversible hypertrophy, and is often described as 
physiological hypertrophy (53). It is unknown whether LV wall thickness might occur as an 
adaptive response to the relative volume overload during pregnancy, or whether changes early 
in pregnancy decrease LV mass which then is recovered in late pregnancy and postpartum. 
Similar responses to increased blood volume and cardiac output over time have been observed 
in athletes (54).  
   Despite the significant changes we found in LV systolic functions during normal pregnancy, 
there were only minor alterations in diastolic function and filling pressures. We used tissue 
Doppler to characterise diastolic function during normal pregnancy, which has been reported 
with discrepant results in earlier and smaller studies (43, 49, 55, 56, 57). We found merely a 
mild, although significant, reduction of e’ during pregnancy. Left atrial size increased during 
pregnancy, probably as a result of increased circulating blood volume. However E/e’, a 
marker of LV filling pressure, remained unaltered during pregnancy as compared to 6 months 
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postpartum control. Furthermore, there was no significant change in deceleration time during 
pregnancy. Despite the increased demand during pregnancy, these findings indicate unaltered 
left ventricular filling pressure during normal pregnancy and postpartum.  
   As a response to the physiological demand on the mother during pregnancy, morphological 
changes are triggered, leading to increased LV wall thickness, mass, and chamber diameters. 
The reduced LV function is probably a consequence of the general physical changes in 
pregnancy. These findings might, assuming that pregnancy has some similarity to moderate 
exercise with increased cardiac output, increased peripheral perfusion (through the uterus 
instead of through musculature), and increased oxygen demand. Pregnancy has been 
described as a stress test for life. Normally the physiological demands are well tolerated. 
However, the implications of added physiological stress as e.g. severe obesity or preeclampsia 
or peripartum cardiomyopathy remains unclear, and is subject of investigation.  
Systemic arterial response and ventriculo-arterial interaction during 
normal pregnancy 
Results on systemic arterial response and ventriculo-arterial interaction during normal 
pregnancy have not been described in the literature. Since loading conditions are substantial 
during pregnancy – we also wanted to apply an analysis of ventriculo-arterial coupling or 
interaction. In paper 2 we present a sequential observational noninvasive follow-up study of 
arterial properties and the interaction of the ventricle and the arterial system during normal 
pregnancy and with a 6 months postpartum control. We found as expected, a significant 
increase in cardiac output, and decrease in blood pressure and peripheral arterial resistance. 
However central aortic properties are less altered. The increased ventriculo-arterial coupling 
index (EaI /ELVI) during normal pregnancy indicates a decrease in left ventricular function not 
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fully compensated for by vascular adaptation. This is in concordance with our findings in 
Paper 1 were data support a true, although transient, reduction in LV contractility. Together, 
our findings in Paper 1 and 2 suggest that a normal pregnancy represents a larger load on the 
cardiovascular system than previously reports have assumed.  
   Worldwide, cardiac events in healthy pregnant women are rare, however heart disease may 
occasionally be disclosed during pregnancy due to the raised cardiac demands. A better 
knowledge of the normal systemic arterial and ventriculo-arterial response to pregnancy is 
needed, and these findings may serve as a basis for clinical follow-up and advisories for 
pregnant women.  
   During normal pregnancy we found that the main adaptation of systemic arterial function 
was a reduced peripheral resistance, whereas proximal aortic stiffness and arterial compliance 
were not significantly changed. In Paper 2 there was a trend towards higher arterial 
compliance in the first, second and third time point compared to nonpregnant state. 
Furthermore, there was also a trend towards lower characteristic impedance also during 
pregnancy. The results indicate that changes in compliance and proximal aortic stiffness are 
small, reflecting that large artery properties remain fairly constant in healthy women during 
normal pregnancy. We found arterial elastance to be significantly decreased early in 
pregnancy. Arterial elastance is strongly influenced by heart rate which increases during 
pregnancy and therefore may explain the change in arterial elastance (58). However the 
reflection magnitude was lower in second and third trimester compared to postpartum control. 
It is likely that the lower reflection coefficient is a result of vasodilatation on the arteriolar 
level and not of substantially altered properties in the larger arteries.   
   The increased demands on the heart during normal pregnancy is further described in Paper 2 
by the change in the interaction between LV and the arterial system, the ventriculo-arterial 
coupling from a state of maximal cardiac efficiency (EaI/ELVI: 0.45) towards a maximal 
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cardiac work (EaI/ELVI: 0.64). When the interaction between the LV and arterial system are 
optimal, i.e. under normal resting conditions, the EaI/ELVI ratio is usually close to unity 0.8-
1.2 (59). In paper 2 we found EaI/ELVI, to be 0.45 both in first trimester and postpartum, 
reflecting an optimized cardiac efficiency. However, the coupling index, EaI/ELVI increased to 
0.64 in third trimester. Peripheral arterial resistance was significantly reduced throughout 
pregnancy when compared to the postpartum state. One would expect that this reduction in 
the external load of the ventricle would reduce the coupling index. The increase in coupling 
index during third trimester that we observed is therefore most likely due to the greater 
relative decrease in LV contractility than the reduction in arterial load. This reflects a shift in 
the ventriculo-arterial coupling from a state of maximized cardiac efficiency towards 
maximized cardiac external work. This is in concordance with our data on reduced LV 
function during normal pregnancy in Paper 1, and underscores the suggestion that pregnancy 
represents a larger load on the cardiovascular system than previously reports have assumed.  
Changes in blood pressure during healthy pregnancy 
Decreased systolic and diastolic blood pressure during pregnancy is well known changes 
during normal pregnancy. In Paper I and 2 we found decreased blood pressure during normal 
pregnancy by using Dinamap. In Paper 3 we compared two different devices, Dinamap and 
Finometer and measured the changes in blood pressure during normal pregnancy. The blood 
pressure was measured with the two different devices (the same population as in Paper 1 and 
2) within 90 min repeatedly, both devices confirmed the same pattern of change during 
pregnancy. The main finding in Paper 3 is that pregnant women have a statistically significant 
drop in SBP, DBP, and MAP around 22–24 weeks of gestation, followed by a progressive 
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increase toward term. This is in concordance with previous reports that there is a mid-
trimester drop in blood pressure during normal pregnancy. The mid trimester drop in blood 
pressure can be explained in two different ways. The progressive increase in blood pressure 
from the first measurement until term may represent a gradual restoration of BP after an initial 
drop very early in pregnancy. Alternatively, as concluded by others, the increase in BP is truly 
progressive, starting immediately after conception.
   The lack of the mid-trimester drop in BP has been suggested to play a predictive role for a 
subsequent development of early-onset preeclampsia (< 34 weeks). This hypothesis is further 
supported by others (60) demonstrating a statistically significant higher SBP, DBP, and MAP 
at 24 weeks gestation in women who developed early-onset preeclampsia compared to both 
normal pregnancies and late-onset preeclampsia. Data from several recent reports have 
provided evidence for the predictive value of uteroplacental and maternal hemodynamics 
early in pregnancy with respect to subsequent development of hypertensive disorders of 
pregnancy (60, 61). Women presenting hypertension in pregnancy and especially women 
developing early-onset preeclampsia should be offered examinations aimed at detecting and 
correcting cardiovascular risk. The incorporation of the predictive value of a hypertensive 
pregnancy may help to reduce the risk of preeclampsia and cardiovascular disease in later life 
for these women. 
   Given the new insight into the relation between pregnancy induced hypertension and later 
cardiovascular disease, detailed knowledge on the changes occurring in normal pregnancy is 
essential. Hypertensive disorders of pregnancy and cardiovascular disease share many risk 
factors (e.g. obesity, metabolic syndrome, diabetes, premature cardiovascular disease, 
endothelial dysfunction, thrombophilias, inflammation and oxidative stress). In agreement 
with previous reports (62-64) we found that a pre-pregnant BMI higher than 25 kg/m2 was 
significantly associated with a higher SBP, DBP, and MAP measured by Finometer at any 
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point in both pregnancy and postpartum. Using Dinamap, only SBP was significantly higher 
in women with a pre-pregnant BMI over 25 kg/m2. In order to evaluate the influence of 
pregestational BMI on the change in BP during pregnancy, we chose BMI higher than 25 
kg/m2 as our cutoff value. This cutoff value has clinical relevance as it includes both 
overweight (BMI > 25 kg/m2) and obese (BMI > 30 kg/m2) women, which represents a group 
of pregnant women with higher risk of pregnancy complications and increased long term 
morbidity and mortality.  
LV function, arterial properties and ventriculoarterial coupling; 
comparison between normal pregnancy, acute preeclamptic 
pregnancy and previously preeclamptic pregnancy 
As underscored above, pregnancy is hemodynamically characterized by increased blood 
volume, cardiac output and heart rate, as well as a decrease in blood pressure and peripheral 
vascular resistance. Our previous work (Paper 1, 2 and 3) using noninvasive techniques 
extended these observations by describing the roles of arterial compliance, characteristic 
impedance and arterial elastance during normal gestation. However, preeclampsia, an entity 
with substantial fetal and maternal morbidity, is characterized by high blood pressure and 
significant less vasodilatation than that observed in normal pregnancy. In Paper 4 we showed 
that the systemic arteries of preeclamptic women are significantly stiffer than observed in 
healthy pregnant women at term, and moreover, that this phenomenon persists 6 months 
postpartum. The physiological response to normal pregnancy (Paper 2) is a reduction of 
arterial stiffness at term with lower total vascular resistance and higher compliance. 
Contrasting this, we found that preeclamptic women had a higher total vascular resistance and 
characteristic impedance, and lower compliance at term than women with healthy pregnancy. 
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Physiologically, central arteries are distensible and buffer the systolic output of the ventricle. 
As such, characteristic impedance represents the aortic impedance to pulsatile inflow from the 
contracting ventricle, and compliance describes the aortic capacity to store a transient increase 
in blood volume, i.e. the systemic arterial volume compliance. The higher characteristic 
impedance and lower compliance we observed in preeclamptic pregnancies at term and 
postpartum, indicate that central large arteries are affected in these patients. Furthermore, the 
results from the 3 year follow-up of previous preeclamptic women (PPEP group) substantiated 
evidence for a maintained increased systemic arterial stiffness and that arterial wall 
malfunction may persist over time in these patients. Biological tissue, including the arterial 
wall, has an exponential pressure-stiffness relation. The steeper slope of this relation at higher 
pressures effectively increases the operating stiffness. Thus, the higher blood pressure in the 
preeclamptic women may have contributed to the observed stiffening of their arterial 
parameters. 
   To answer this, arterial pressure levels may be therapeutically reduced in the preeclamptic 
groups and then compare the mechanical properties to healthy pregnancies at matched blood 
pressure. This is a hypothesis that is difficult to test because the pressure change must be 
obtained without use of vasoactive substances, and in absence of any change in 
neurohormonal status.  
   Cardiovascular diseases increase with advancing age and are associated with ventricular and 
arterial stiffening. The changes in characteristic impedance and compliance we observed in 
women with preeclampsia bears a similarity to those reported in patients as a result of aging, 
hypertension, and arteriosclerosis. Hence, our results provide further insight into the 
patophysiological basis for the increased risk of cardiovascular events in women with 
previous PE (65-67).  
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   The ventriculo-arterial coupling, meaning the interaction of the heart with the systemic 
vasculature, is a key determinant of cardiovascular performance, and influence both 
magnitude and efficiency of transfer of LV stroke volume to the circulation. As given in Paper 
2 the LV elastance index, ELVI, is recognised as an important indicator of LV performance. At 
term, ELVI averaged 87% higher in women with preeclamptic pregnancies versus women with 
normal pregnancy. Whereas ELV increases from term to the postpartum state in normal 
pregnancy, it decreases in preeclamptic pregnancies. Six months postpartum, LV elastance in 
the PE group are still 14% higher than in the normal pregnancy group. Our results suggests 
that cardiac performance first is substantially influenced during a preeclamptic pregnancy, and 
is postpartum then followed by a restoration process which is not complete at 6 months. 
However, patients attained a normal state 3 years postpartum as demonstrated by the 
comparable levels of ELVI in the normal pregnancy and PPEP group. We reported in Paper 2 
that in healthy normal pregnancies, there is a shift towards increased cardiac work load 
evident by a progressive increase in ventriculo-arterial coupling towards term, followed by a 
restoration of work efficiency postpartum. The substantially higher EaI in PE compared to NP 
is balanced by a correspondingly higher ELVI, leaving the ratio Ea/ELV unchanged from term 
to postpartum in PE. The resulting coupling index values are at the level where work 
efficiency of the heart is considered maximal (34, 35). 
   The alterations in circulating blood volume, blood pressure, peripheral vascular resistance, 
compliance, myocardial function, heart rate and the neurohormonal system, all allow the 
cardiovascular system to meet the increased metabolic demands of pregnancy.
   This thesis shows that we non-invasively by use of an echocardiographic evaluation of left 
ventricle combined with tonometric external pulse trace recording can add important 
information on the interaction of the heart with systemic vasculature in patients susceptible 
for gestational cardiovascular disorders like preeclampsia, hypertension and peripartum 
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cardiomyopathy. Furthermore, maternal hemodynamic influence fetal growth and thereby 
current and future health of the newborn (68). Finally, hemodynamic characteristics during 
pregnancy may add to the current risk stratification tools in terms of predicting future 
cardiovascular disease. Insight into the mechanisms of physiological changes in normal 
pregnancy is essential in follow up of pregnant women with maternal structural heart disease 
and pregnancy.  
Limitations 
Preconceptional data would be the preferred reference measurements for assessing 
hemodynamic alterations during pregnancy, especially since we know that the major changes 
occurs already during the first 12 weeks of pregnancy (28). We used the 6 months postpartum 
control as the reference point which is generally regarded reasonable because most 
hemodynamic parameters return to preconception values within 8-12 weeks after delivery 
(29). However, some of our parameters were maintained increased at 6 months postpartum 
control, suggesting that normalization of postpartum hemodynamic takes longer time than 
presently assumed. 
   There are ethnic variations in cardiac function and arterial properties. In our population of 
women with normal pregnancy (paper 1, 2, 3 and 4), 97% were Caucasian. 
Hormone and hormonal contraceptives might have influence on hemodynamic and arterial 
properties, unfortunately we lack information about breast feeding and use of hormonal 
contraceptives at 6 months control. 
   Since data for the PPEP was obtained in a cross-sectional study sample, comparisons 
between this group and the PE group must be interpreted with some caution. However, the 
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general patients’ characteristics of the two groups were not different supporting that their 
status were comparable. Furthermore, we do not have access to pregestational data in any of 
the study groups, which proscribes any inference of cause-effect relationship between 
development of preeclampsia and the reported changes in arterial properties and persisting 
hypertension in previous preeclamptic women.  
   Longitudinal data during pregnancy in preeclamptic women would be preferable, in order to 
detect hemodynamic changes early in pregnancy that may be present before preeclampsia 
becomes clinically overt and which ones that occurs after clinical manifestation of the 
disorder.
   Furthermore, studies of larger size than the present one would  make it possible to study 
hemodynamic feature in subgroups of preeclamptic women like those with early and late 
onset preeclampsia,  with or without foetal growth restriction and  with and without pre-
existing metabolic disorders like diabetes and metabolic syndrome.  
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Main conclusions 
1.  During normal pregnancy, profound alterations in LV function occur. Increases in 
circulating blood volume are reflected by increased CO and cardiac dimensions. LV 
contractility is significantly reduced, whereas filling pressures (e/e’) are unchanged. These 
findings suggest that pregnancy represents a larger load on the cardiovascular system than 
previously assumed. Reference values obtained are relevant in order to identify cardiovascular 
dysfunction in pregnant women with heart disease. 
2.  During normal pregnancy there is an increase in cardiac output, and decrease in blood 
pressure and peripheral arterial resistance whereas central aortic properties are less altered. 
The increased ventriculoarterial coupling index (EaI/ELVI) during normal pregnancy indicates 
a decrease in LV function not fully compensated for by vascular adaptation. 
3.  Blood pressure measured repeatedly by two different noninvasive devices during 
pregnancy and postpartum showed a statistically significant drop in mid-pregnancy, followed 
by a progressive increase until term. The lack of the mid-trimester drop in blood pressure 
might play a predictive role for a subsequent development of early-onset preeclampsia. 
4.  Women with established preeclampsia are characterised by a higher resistance in the entire 
arterial system. The altered arterial properties persisted after six months and were also 
elevated three years postpartum in women with previous preeclamptic pregnancy. These 
changes indicate that preeclampsia induces persistent cardiovascular disturbances.  
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Future perspectives 
Given that the cardiovascular system is affected in normal pregnancy, is deranged in 
preeclampsia, and that preeclampsia is an indicator of future cardiovascular risk, 
investigations of the cardiovascular system in pregnant women will be an important topic in 
studies of women’s health. To follow-up this women close, has to be an important future 
perspective. It will not only be important to diagnose women who will develop early 
preeclampsia, but also to follow-up women who has suffered from previous preeclampsia. 
Our study shown maintained increased arterial stiffness 3 years after pregnancy, and the 
woman were still hypertensive. None of them were on antihypertensive medication.  
Some countries now use preeclampsia as a risk factor compared to smoking, diabetes and 
obesity for development of CVD. This thesis supports the view that also Norway should 
implement preeclampsia in risk stratification for cardiovascular disease. We need further and 
larger study including women with previous preeclampsia to see if their arterial stiffness 
maintain over year. 
   Finally, despite advances in the prevention and management of CVD, this group of 
multifactorial disorders remains a leading cause of mortality worldwide. CVD is associated 
with multiple genetic and modifiable (environmental) risk factors (69). However, known 
environmental and genetic influences can only explain a small part of the variability in CVD 
risk. More recently the fetal environment and its role in predisposing an individual for 
diseases later in life has attracted increasing attention (70). For example is it well documented 
that poor growth conditions during fetal life is a significant risk factor for cardiovascular 
disease and diabetes.  Fetal nutritional conditions play a major role in this in utero 
“programming“of later predisposition for disease. There is some evidence that maternal 
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hemodynamic features are associated with fetal growth (68). Besides maternal nutritional 
intake and metabolic status, maternal hemodynamics may take part in determining the growth 
conditions of the foetus probably by modifying placental blood perfusion.  
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